Literature DB >> 18775763

Time dependency of uterine effects of naringenin type phytoestrogens in vivo.

Oliver Zierau1, Georg Kretzschmar, Frank Möller, Carmen Weigt, Günter Vollmer.   

Abstract

Phytoestrogens exhibit significant estrogen agonistic/antagonistic properties in animals and humans. Naturally occurring flavonoids with a naringenin backbone like 8-prenylnaringenin (8-PN) and 6-(1,1-dimethylallyl)naringenin (6-DMAN) are considered to be some of the most potent phytochemicals activating nuclear receptors. 8-PN is a more potent estrogenic substance while 6-DMAN appears to have a higher antiandrogenic potency, however these are less well characterized compared to other phytoestrogens such as genistein. The aim of this study was to assess the estrogenic properties of 8-PN and 6-DMAN in an ovariectomized in vivo rat model. 8-PN and 6-DMAN were applied at concentrations of 15mg/kgBW. We assessed the uterotrophic response after 7h, 24h and 72h of treatment. In contrast to 8-PN, 6-DMAN did not alter uterine wet weight or the level of expression of proliferation markers at any time point. In contrast to the uterotrophic response, 6-DMAN stimulated uterine mRNA expression of estrogen responsive genes carrying an estrogen response element (ERE) in the ovariectomized rats, but to a lesser extent than E2 and 8-PN. In all treatment regimens, the mRNA expression of estrogen receptors alpha and beta mRNA was measured. In summary, we assessed the time dependent uterine responses and estrogenic activities of 6-DMAN and 8-PN. In contrast to 8-PN which mimicked the E2 induced responses on uterine wet weight and gene expression, 6-DMAN has no uterotrophic effect and only regulated the mRNA expression of genes carrying an ERE. Therefore, 6-DMAN is an exciting candidate molecule for future investigations and potentially a natural occurring selective estrogen receptor modulator.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18775763     DOI: 10.1016/j.mce.2008.08.008

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  6 in total

1.  Evaluation of estrogenic potency of a standardized hops extract on mammary gland biology and on MNU-induced mammary tumor growth in rats.

Authors:  Annekathrin M Keiler; Dana Macejova; Birgit M Dietz; Judy L Bolton; Guido F Pauli; Shao-Nong Chen; Richard B van Breemen; Dejan Nikolic; Florian Goerl; Michael H Muders; Oliver Zierau; Günter Vollmer
Journal:  J Steroid Biochem Mol Biol       Date:  2017-09-28       Impact factor: 4.292

2.  Combination Therapy of Sophoraflavanone B against MRSA: In Vitro Synergy Testing.

Authors:  Su-Hyun Mun; Ok-Hwa Kang; Dae-Ki Joung; Sung-Bae Kim; Yun-Soo Seo; Jang-Gi Choi; Young-Seob Lee; Seon-Woo Cha; Young-Sup Ahn; Sin-Hee Han; Dong-Yeul Kwon
Journal:  Evid Based Complement Alternat Med       Date:  2013-11-10       Impact factor: 2.629

3.  Cross-Talk in the Female Rat Mammary Gland: Influence of Aryl Hydrocarbon Receptor on Estrogen Receptor Signaling.

Authors:  Janina Helle; Manuela I Bader; Annekathrin M Keiler; Oliver Zierau; Günter Vollmer; Sridar V Chittur; Martin Tenniswood; Georg Kretzschmar
Journal:  Environ Health Perspect       Date:  2015-09-15       Impact factor: 9.031

4.  Semi-Synthetic Approach Leading to 8-Prenylnaringenin and 6-Prenylnaringenin: Optimization of the Microwave-Assisted Demethylation of Xanthohumol Using Design of Experiments.

Authors:  Corinna Urmann; Herbert Riepl
Journal:  Molecules       Date:  2020-09-02       Impact factor: 4.411

5.  Manipulating Estrogenic/Anti-Estrogenic Activity of Triphenylethylenes towards Development of Novel Anti-Neoplastic SERMs.

Authors:  Heba E Elnakib; Marian M Ramsis; Nouran O Albably; Merna A Vector; Jan J Weigand; Kai Schwedtmann; Jannette Wober; Oliver Zierau; Günter Vollmer; Ashraf H Abadi; Nermin S Ahmed
Journal:  Int J Mol Sci       Date:  2021-11-22       Impact factor: 5.923

Review 6.  The Potent Phytoestrogen 8-Prenylnaringenin: A Friend or a Foe?

Authors:  Raimo Pohjanvirta; Atefeh Nasri
Journal:  Int J Mol Sci       Date:  2022-03-15       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.